首页> 外国专利> METHOD OF PRIMARY LIVER CANCER TREATMENT AND KIT FOR PRIMARY LIVER CANCER TREATMENT

METHOD OF PRIMARY LIVER CANCER TREATMENT AND KIT FOR PRIMARY LIVER CANCER TREATMENT

机译:原发性肝癌的治疗方法及原发性肝癌的治疗套件

摘要

FIELD: medicine, oncology. SUBSTANCE: method involves administration of doxorubicin dissolved in lipiodol ultrafluid in hepatic artery. Doxorubicin preparation used - doxorubicin-estrone dissolved in 96% ethanol at 70-76 C, dose is 20-60 mg per 10-15 ml lipiodol ultrafluid. Preliminary, 20 min. before, alpha-fetoprotein is administrated in hepatic artery at dose 2-10 mg in 12-15 saline solution and repeated treatment is carried out in 3-4 weeks. Kit for treatment contains doxorubicin preparation and lipiodol ultrafluid, and doxorubicin preparation is sterile doxorubicin-estrone (20-60 mg in vials, volume is 15 ml), sterile lipiodol ultrafluid in two ampoules by 10 ml and, additionally, sterile lyophilized preparation of human alpha-fetoprotein at amount 1-10 mg in vials by 10 ml, sterile saline solution (15 ml in ampoule) and 96% ethanol (5 ml in ampoule). Method can be used for chemotherapy of oncological patients. EFFECT: improved method of treatment. 3 cl, 1 tbl
机译:领域:医学,肿瘤学。物质:该方法涉及给予溶解在肝动脉中碘油超流体中的阿霉素。使用的阿霉素制剂-将阿霉素雌酮在70-76°C下溶于96%乙醇,剂量为每10-15毫升碘油超流体20-60毫克。初步的20分钟。在此之前,将甲胎蛋白以2-10 mg的剂量在12-15盐水溶液中给予肝动脉,并在3-4周内重复治疗。用于治疗的试剂盒包含阿霉素制剂和脂质体超流体,并且阿霉素制剂是无菌的阿霉素雌酮(小瓶中20-60 mg,体积为15 ml),两个安瓿中的无菌脂质体超流体10 ml,另外还有人的无菌冻干制剂甲胎蛋白的量为10毫升装在小瓶中的10毫升,无菌盐溶液(安瓿瓶中为15毫升)和96%乙醇(安瓿瓶中为5毫升)。该方法可用于肿瘤患者的化疗。效果:改进的治疗方法。 3厘升,1汤匙

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号